Receptor-mediated clearance of Cryptococcus neoformans capsular polysaccharide in vivo
about
Cryptococcus-Related Immune Reconstitution Inflammatory Syndrome (IRIS): Pathogenesis and its Clinical ImplicationsCryptococcus and Phagocytes: Complex Interactions that Influence Disease OutcomeElucidating the immunological function of the Cryptococcus neoformans capsuleStructure and function relations with a T-cell-activating polysaccharide antigen using circular dichroism.TLR9 signaling is required for generation of the adaptive immune protection in Cryptococcus neoformans-infected lungs.Glucuronoxylomannan, galactoxylomannan, and mannoprotein occupy spatially separate and discrete regions in the capsule of Cryptococcus neoformans.Binding of the wheat germ lectin to Cryptococcus neoformans chitooligomers affects multiple mechanisms required for fungal pathogenesis.Cryptococcus neoformans glucuronoxylomannan fractions of different molecular masses are functionally distinct.Role of sphingosine-1-phosphate (S1P) and S1P receptor 2 in the phagocytosis of Cryptococcus neoformans by alveolar macrophagesTherapeutic efficacy of a conjugate vaccine containing a peptide mimotope of cryptococcal capsular polysaccharide glucuronoxylomannanEvolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36The capsule of the fungal pathogen Cryptococcus neoformans.Macrophage Cryptococcus interactions: an update.Capsular Material of Cryptococcus neoformans: Virulence and Much More.Immunomodulatory effects of serotype B glucuronoxylomannan from Cryptococcus gattii correlate with polysaccharide diameter.Klebsiella pneumoniae increases the levels of Toll-like receptors 2 and 4 in human airway epithelial cells.Glucuronoxylomannan from Cryptococcus neoformans down-regulates the enzyme 6-phosphofructo-1-kinase of macrophages.RNA Interference Screening Reveals Host CaMK4 as a Regulator of Cryptococcal Uptake and Pathogenesis.Immune Recognition of Fungal Polysaccharides.Cryptococcal pathogenic mechanisms: a dangerous trip from the environment to the brain.Decreased TLR2 signal expression in peripheral blood mononuclear cell from patients with cryptococcal meningitis.Innate Immunity against Cryptococcus, from Recognition to Elimination.
P2860
Q24629367-C2DB40D3-10BA-49A6-81A1-603085540F9AQ26767978-E92AB072-1314-4170-9880-CE1BB25571D3Q26859234-55B35435-A2BA-4CF3-9D2B-E656D82A55B7Q33989161-07639A4C-0E82-43DD-8903-2AD3CD9E41CFQ34033551-8CD6C3E1-8F72-4F02-889F-B486F65773D8Q34775729-94CBB41E-E5B6-40A8-877C-D78BD9AF1722Q34961051-76F994D0-1AD2-41B6-8B25-164C2AD457D7Q34961105-926F05CA-56BB-4523-BB16-23A1BC3C8B15Q35118828-C22912A2-01F9-4D27-8DF2-ED04C302770DQ36844895-8376CB78-315A-4B61-A313-273251EBD08EQ37234285-F4A58FA3-D2F3-4E61-8515-E304812A8A7BQ37337879-0C1F9610-2179-4913-92D2-D33617F7D4A9Q37645657-6A3A767A-F470-49C0-9E72-7C797E8AA27FQ37982326-F128FF44-65AF-4AAE-BA41-48A689E62197Q39693119-F4DCDEB8-05C4-40B3-8D9D-CCA87DF54599Q39915508-07F71AA0-10FD-4B12-BB45-5A12AB5CD442Q42722736-8351FC69-FF9C-46AF-AC30-465F0826DC45Q47712336-F022E9B3-BEA8-4257-9A81-6F3180FDB1B5Q48163129-F9E4982E-8CC6-4888-B9ED-51658CCC22F0Q52580472-812DA22C-712E-456C-A8AA-D05F1F841932Q53514240-DE6C0E6B-CF19-48C8-975B-21A069E81777Q55421879-C1F0F27C-FE0F-4CCF-97D2-7E5276D78788
P2860
Receptor-mediated clearance of Cryptococcus neoformans capsular polysaccharide in vivo
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Receptor-mediated clearance of Cryptococcus neoformans capsular polysaccharide in vivo
@ast
Receptor-mediated clearance of Cryptococcus neoformans capsular polysaccharide in vivo
@en
Receptor-mediated clearance of Cryptococcus neoformans capsular polysaccharide in vivo
@nl
type
label
Receptor-mediated clearance of Cryptococcus neoformans capsular polysaccharide in vivo
@ast
Receptor-mediated clearance of Cryptococcus neoformans capsular polysaccharide in vivo
@en
Receptor-mediated clearance of Cryptococcus neoformans capsular polysaccharide in vivo
@nl
prefLabel
Receptor-mediated clearance of Cryptococcus neoformans capsular polysaccharide in vivo
@ast
Receptor-mediated clearance of Cryptococcus neoformans capsular polysaccharide in vivo
@en
Receptor-mediated clearance of Cryptococcus neoformans capsular polysaccharide in vivo
@nl
P2093
P2860
P1476
Receptor-mediated clearance of Cryptococcus neoformans capsular polysaccharide in vivo
@en
P2093
Lauren E Yauch
Michael K Mansour
Stuart M Levitz
P2860
P304
P356
10.1128/IAI.73.12.8429-8432.2005
P407
P577
2005-12-01T00:00:00Z